News
-
-
COMMUNIQUÉ DE PRESSE
Fiscal Year 2025: FORVIA HELLA achieves robust financial results in a challenging market environment
FORVIA HELLA achieves robust financial results in a challenging market environment for fiscal year 2025, with stable sales at €8.0 billion and operating income margin at 6.0 percent -
COMMUNIQUÉ DE PRESSE
HomeToGo publishes 2025 Annual Report and 2026 strategic roadmap: Focus on Interhome integration and profitability growth
HomeToGo SE publishes 2025 Annual Report and 2026 strategic roadmap focusing on Interhome integration and profitability growth. Financial targets exceed expectations -
-
COMMUNIQUÉ DE PRESSE
DocMorris and Google partner to advance one of Europe’s leading AI-powered digital health platform
DocMorris and Google partner to advance digital health platform with AI technology, enhancing patient services. Google's AI capabilities and secure cloud infrastructure utilized for innovative healthcare solutions -
COMMUNIQUÉ DE PRESSE
Newron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 Finance Contract
Newron Pharmaceuticals S.p.A. announces agreement with EIB to extend 2018 Finance Contract tranche repayment dates to June 28, 2028, focusing on lead drug candidate evenamide for treatment-resistant schizophrenia -
-
COMMUNIQUÉ RÉGLEMENTÉ
bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
bioMérieux receives IVDR CE-marking for two BIOFIRE SPOTFIRE panels enhancing near-patient respiratory and sore throat diagnostics across Europe -
COMMUNIQUÉ RÉGLEMENTÉ
bioMérieux obtient le marquage CE IVDR pour deux tests BIOFIRE® SPOTFIRE® afin de renforcer en Europe le diagnostic des infections respiratoires et pharyngées au plus près du patient
bioMérieux obtient le marquage CE IVDR pour ses tests BIOFIRE® SPOTFIRE® R/STplus Panel et R/STplus Panel Mini, renforçant le diagnostic des infections respiratoires et pharyngées en Europe -
COMMUNIQUÉ RÉGLEMENTÉ
Résultats annuels 2025 et nouvelle signature stratégique
